We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Notice for oveporexton (Takeda Pharmaceuticals Australia Pty Ltd)
Active ingredients
oveporexton
Date of review outcome
Lapse date
Type
Priority review
Indication
Treatment of narcolepsy type 1
Therapeutic area
Sleep medicine